Collection
Recent Advances in Breast Invasive Carcinoma Research and Treatment
Invasive breast cancer is a major challenge in the field of oncology and requires continuous research and innovative treatment approaches. Understanding the genetic and molecular landscape of invasive breast cancer is crucial for improving diagnostic accuracy and developing targeted therapies. The discovery of specific molecular subtypes in invasive breast cancer paves the way for more personalized treatment approaches. In addition, immunotherapy is an important step in the diagnosis and treatment of invasive breast cancer. Immunotherapy agents can be designed to harness the body's immune system to target and destroy cancer cells. Clinical trials investigating the efficacy of immunotherapy in invasive breast cancer show encouraging results and offer a glimpse of a potential paradigm shift in treatment strategies. Investigating the synergistic effects between targeted therapies, immunotherapy, systems biology and the integration of artificial intelligence in the analysis of large data sets is very important to increase diagnostic accuracy and therapeutic decision-making in clinical trials of invasive breast cancer.
Our goal is to comprehend the mechanisms underlying diagnosis and therapeutic approaches in invasive breast cancer. Contributors are invited to address the following, but not limited to, themes:
1) Molecular mechanisms in invasive breast cancer immunotherapy 2) Novel techniques for identifying biomarkers in invasive breast cancer 3) Combination therapies in invasive breast cancer 4) Overcoming challenges and limitations of invasive breast cancer treatment 5) Personalized medicine in invasive breast cancer 6) Drug repurposing in invasive breast cancer 7) Small molecules or natural products for anti-invasive breast cancer
Keywords: invasive breast cancer, genetic and molecular landscape, personalized medicine
Editors
-
Junjiang Fu
Professor, PhD, Southwest Medical University, China
He is a distinguished professor of Luzhou Medical College and the director of the Basic Medical Research Center of Luzhou Medical College. He obtained a doctorate from Xiangya Medical College of Central South University and worked as a postdoctoral fellow at Baylor College of Medicine in the United States. He founded the "Tumor Epigenetics" Provincial Key Laboratory for universities in Sichuan, as well as the Sichuan Provincial Medical Key Laboratory focused on "Epigenetics and Tumors".
